The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 study of REGN4336 alone or in combination with cemiplimab or nezastomig in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
 
William Kelly
Honoraria - Amgen; Janssen Oncology
Consulting or Advisory Role - Amgen; Bayer; Janssen Oncology
Research Funding - Amgen (Inst); Bayer (Inst); BioClin Therapeutics (Inst); Endocyte (Inst); Exelixis (Inst); Janssen Oncology (Inst); Novartis (Inst); Regeneron (Inst); Roche (Inst); Sarah Cannon Research Institute (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Sandy Srinivas
Consulting or Advisory Role - Eisai; Janssen Oncology; Novartis; Seagen
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Seattle Genetics/Astellas (Inst)
Other Relationship - Pfizer
 
Joseph Maly
No Relationships to Disclose
 
Deepak Kilari
Honoraria - Exelixis
Consulting or Advisory Role - Eisai; Exelixis; Janssen Oncology; Pfizer
Speakers' Bureau - Astellas Pharma; AVEO; Eisai; Exelixis; Janssen
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Exelixis; Janssen
 
Arif Hussain
Consulting or Advisory Role - AstraZeneca; Bayer; Exelixis; Janssen Oncology
Research Funding - Bayer; Clovis Oncology; Constellation Pharmaceuticals (Inst); Infinity Pharmaceuticals; Merck Sharp & Dohme; Nektar; Pfizer; Roche/Genentech; Sotio
 
Biren Saraiya
Research Funding - Hookipa Pharma (Inst); Merck (Inst); OncoC4 (Inst); Regeneron (Inst)
 
Bilal Siddiqui
Research Funding - Regeneron (Inst)
 
Paul Monk
Consulting or Advisory Role - Dendreon; Myovant Sciences; Pfizer/NCCN; Sanofi
Research Funding - Arvinas (Inst); Bayer (Inst); BioXCell (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); regeneron (Inst)
 
Gurkamal Chatta
Consulting or Advisory Role - Cardinal Health
Research Funding - Abbvie (Inst); Taiho Oncology (Inst)
Travel, Accommodations, Expenses - Cardinal Health
 
Vivek Narayan
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Janssen Oncology; Merck; Myovant Sciences; Pfizer/Astellas; Regeneron; Sanofi; Terns Pharmaceuticals; Xencor
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - US Patent No. 18/708,529
Travel, Accommodations, Expenses - Eisai; Pfizer
 
Divya Rana
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Pradeep Thanigaimani
Employment - Regeneron
Stock and Other Ownership Interests - Celularity Inc; Inovio Pharmaceuticals; Lilly; Mannkind; Novo Nordisk; Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Fang Fang
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Dimitris Skokos
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Jessica Kirshner
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Frank Seebach
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Israel Lowy
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron
 
Matthew Ingham
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Consulting or Advisory Role - Apexigen; Caris Life Sciences; Daiichi Sankyo; Epizyme; Xencor
Research Funding - Apexigen (Inst); APICES; Astellas Pharma (Inst); AstraZeneca (Inst); Bioatla (Inst); Boehringer Ingelheim (Inst); Intensity (Inst); Merck (Inst); Mirati Therapeutics (Inst); PTC Therapeutics (Inst)
 
Sabina Sandigursky
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Elizabeth Miller
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron